{"id":"olimel-n12","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Phlebitis at infusion site"},{"rate":null,"effect":"Electrolyte imbalances"},{"rate":null,"effect":"Hepatic dysfunction"}]},"_chembl":{"chemblId":"CHEMBL3897235","moleculeType":"Small molecule","molecularWeight":"401.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Olimel N12 is a complete all-in-one parenteral nutrition formulation combining amino acids for protein synthesis, glucose for energy, and lipid emulsion for essential fatty acids and additional calories. It is designed for intravenous administration to provide comprehensive nutritional support in clinical settings where oral or enteral feeding is not feasible or insufficient.","oneSentence":"Olimel N12 is a parenteral nutrition emulsion that provides balanced macronutrients (amino acids, glucose, and lipids) to support metabolic needs in patients unable to eat orally.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:39:12.326Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition support in patients unable to receive adequate oral or enteral nutrition"},{"name":"Post-operative nutritional support"},{"name":"Critical illness and intensive care nutrition"}]},"trialDetails":[{"nctId":"NCT04094038","phase":"PHASE4","title":"The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2019-09-16","conditions":"End Stage Renal Disease, Malnutrition, Sarcopenia","enrollment":166},{"nctId":"NCT07254897","phase":"NA","title":"Long-term Muscle Synthetic Effects of Intradialytic Parenteral Nutrition in Chronic Hemodialysis Patients","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2026-01-01","conditions":"Malnutrition or Risk of Malnutrition","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Olimel N12","genericName":"Olimel N12","companyName":"Erasmus Medical Center","companyId":"erasmus-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Olimel N12 is a parenteral nutrition emulsion that provides balanced macronutrients (amino acids, lipids, and carbohydrates) to support metabolic needs in patients unable to eat orally. Used for Total parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Post-operative nutritional support, Critical illness with gastrointestinal dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}